4.7 Article

Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure

Journal

SCIENTIFIC REPORTS
Volume 12, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-022-10857-x

Keywords

-

Funding

  1. European Community under the Innovative Medicine Initiative project MIP-DILI [115336]
  2. BMBF (Her2Low) [031A429B]
  3. Ministry of Science, Research and the Arts Baden-Wuerttemberg
  4. Joachim Herz Stiftung
  5. bwHPC initiative (high-performance computing in Baden-Wuerttemberg, Germany)

Ask authors/readers for more resources

This study presents a quantitative dynamic model that accurately describes the dynamic response of cells to oxidative stress. The model can explain the activation of the Nrf2 pathway by compounds with different activation mechanisms, and reveal differences in the activation dynamics of drug-induced liver injury (DILI) inducing drugs.
Cells are exposed to oxidative stress and reactive metabolites every day. The Nrf2 signaling pathway responds to oxidative stress by upregulation of antioxidants like glutathione (GSH) to compensate the stress insult and re-establish homeostasis. Although mechanisms describing the interaction between the key pathway constituents Nrf2, Keap1 and p62 are widely reviewed and discussed in literature, quantitative dynamic models bringing together these mechanisms with time-resolved data are limited. Here, we present an ordinary differential equation (ODE) based dynamic model to describe the dynamic response of Nrf2, Keap1, Srxn1 and GSH to oxidative stress caused by the soft-electrophile diethyl maleate (DEM). The time-resolved data obtained by single-cell confocal microscopy of green fluorescent protein (GFP) reporters and qPCR of the Nrf2 pathway components complemented with siRNA knock down experiments, is accurately described by the calibrated mathematical model. We show that the quantitative model can describe the activation of the Nrf2 pathway by compounds with a different mechanism of activation, including drugs which are known for their ability to cause drug induced liver-injury (DILI) i.e., diclofenac (DCF) and omeprazole (OMZ). Finally, we show that our model can reveal differences in the processes leading to altered activation dynamics amongst DILI inducing drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available